A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients

NCT00002399 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Candidiasis, Oral
HIV Infections

Interventions

DRUG: Posaconazole
DRUG: Fluconazole

Sponsor

Schering-Plough